Experimental validation of cuproptosis-associated molecular signatures and their immunological implications in pulmonary tuberculosis.
Source check: Source checked. Not independent scientific confirmation.
Finding: LASSO and random forest prioritized tuberculosis-associated genes; independent datasets, patient assays, and treatment-time samples supported the biomarker result.
Technology: GSE83456 discovery and GSE42834/GSE89403 validation are supplemented by RT-qPCR and Western-blot patient samples.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- GSE83456 discovery and GSE42834/GSE89403 validation are supplemented by RT-qPCR and Western-blot patient samples.
- Test and result
- Primary Results describe the specific comparator, cohort or experimental check; limitations are stated narrowly.
- Limitation / still unknown
- The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1570992/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.